Wednesday, August 19, 2026

HomeHealth NewsCombination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

- Advertisement -

Credit: Pixabay/CC0 Public Domain

Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 200,000 people in the United States.

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed